Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Metopimazine - Neurogastrx

Next Previous
Search
Drug Profile

Metopimazine - Neurogastrx

Alternative Names: NG 101

Latest Information Update: 18 Oct 2024

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Neurogastrx
  • Class Antiemetics; Gastrokinetics; Phenothiazines; Piperidines
  • Mechanism of Action Dopamine D2 receptor antagonists; Dopamine D3 receptor antagonists; Dopamine receptor modulators; Serotonin receptor modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Phase II Gastroparesis; Obesity
  • No development reported Gastrointestinal disorders

Most Recent Events

  • 16 Oct 2024 Neurogastrx plans to discuss with the US FDA to initiate a phase II/III trial for Obesity in 2025
  • 13 Sep 2024 Neurogastrx completes a phase II trial in Obesity (In volunteers) in USA (SC) (NCT06500429)
  • 24 Jun 2024 Phase-II clinical trials in Obesity (In volunteers; Adjunctive treatment) in USA (SC) (NCT06500429)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top